Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 09, 2022
Emmes announced the creation of a dedicated center to enhance Emmes’ legacy and depth in cell and gene therapy research.
read more
Enable Injections has entered into a multi-product development agreement with Sanofi S.A.
read more
Wednesday, April 17, 2019
Encube Ethicals has announced its new high potency manufacturing facility for topical formulations is now fully operational.
read more
Wednesday, November 17, 2021
Endo International plc announced that its subsidiary, Par Sterile Products, LLC (Par Sterile), has entered into a cooperative agreement to expand its sterile fill-finish manufacturing production capacity and capabilities at its Rochester, Michigan ...
read more
FDA is issuing this guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19...
read more
Wednesday, October 07, 2015
Envirotainer now launches a new service – an Availability Guarantee that ensures availability of RKN e1 containers at all European locations for all shippers. This unique offering in the market will support the pharmaceutical industry in supplying ...
read more
Thursday, October 07, 2021
Samsung Biologics and Enzolytics (ENZC) announced the signing of a strategic CDMO partnership agreement. Under the terms of the agreement, Samsung Biologics will provide end-to-end CDMO services from cell line development, clinical drug substance, ...
read more
Monday, September 22, 2014
The rise of high value specialty pharmaceuticals, growth of the generics market, smaller order sizes and increasing label complexity are driving demand for shorter batch color labels. With the Drug Quality and Security Act’s (DQSA) impending ...
read more
Eremid Research Services has been established as the new name for the commercial arm of the 501(c)(3) non-profit, research organization - DHMRI.
read more
The CCMI at the NUI Galway and Sexton Biotechnologies announced the approval by an EU Regulatory Authority of a protocol for the manufacture of allogeneic bone marrow MSCs to be given intravenously to high-risk corneal transplant recipients in the ...
read more
EUROAPI has expanded its collaboration with Sanofi under the umbrella of their Master Agreement for Development and GMP Manufacturing Services (the “DSA”), dated October 1, 2021, to support Sanofi’s mRNA vaccine platform with the development of lipid...
read more
Starting in July, the commercial brand for Eurofins Alphora will be Eurofins CDMO, falling under the CDMO umbrella in conjunction with Eurofins Amatsigroup.
read more
Eurofins Discovery announced the acquisition of DiscoveryBioMed, a contract research organization (CRO) focused on developing novel human bioassays utilizing cells from diseased and normal human tissues.
read more
Eurofins Discovery announced the formation of its new Scientific Advisory Board (SAB). Company officials gathered renowned leaders from the pharmaceutical and biotechnology industries to gain strategic insights to address the unmet needs in drug ...
read more
Tuesday, February 13, 2018
Eurofins Food Safety Systems (EFSS) and Orion Assessment Services partner to expand auditing and certification services throughout Canada.
read more